Audrey G.

Audrey G. has extensive experience in the biopharmaceutical and healthcare industries. Audrey is the Co-Founder and Chief Business Officer of the Center for Breakthrough Medicines, where they oversee strategic business development and is responsible for management team formation, board of directors' oversight, and capital procurement. Audrey also serves as a Board Member for NLS Pharmaceutics AG, New York Mortgage Trust, Inc., The Chamber of Commerce for Greater Philadelphia, and the King of Prussia District. Additionally, they are a Board Member of the Innovation Advisory Board at Abramson Cancer Center and a Member of Break into the Boardroom (BiB), which promotes parity board representation for executive women in the healthcare industry. Audrey is also an Advisory Board Member for Phacilitate and serves on the Life Sciences Advisory Board and FemTech Advisory Board for the Philadelphia Alliance for Capital and Technologies (PACT). Prior to their current roles, Audrey was a Co-Founder of Discovery Labs, a life science real estate ecosystem.

Audrey G. pursued their education with a Bachelor of Science in Business Administration (BSBA) degree, majoring in Accounting and Finance, from the University of Arizona. This educational journey took place between 1990 and 1994. Subsequently, Audrey enrolled in The Wharton School to earn an MBA in Finance, which they accomplished from 1998 to 2000.

Throughout their education, Audrey also obtained various certifications. These include the Series 63 certification from FINRA, which they acquired in September 2000. Additionally, they hold a Certified Public Accountant (CPA) certification from the Illinois CPA Society. The specific month and year of obtaining this certification are not provided. It is also mentioned that Audrey has a Series 7 certification from FINRA, but the timing of its acquisition is unknown.